World Patient Safety Day 2023
13 Sep 2023 4 min
We know how important it is to stay up-to-date with the latest news, regulatory updates and results from key clinical trials. This section will keep you at the forefront of recent advances in the pharmaceutical industry, including science-backed therapeutic benefits of vitamin active pharmaceutical ingredients, events and dsm-firmenich’s latest business developments.
13 Sep 2023 4 min
04 May 2023 4 min
04 Aug 2022 4 min
25 May 2022 4 min
10 May 2022 4 min
10 May 2022 5 min
04 Feb 2022 5 min
21 Jan 2021 4 min
19 Jun 2020 7 min
23 Jul 2019 3 min
dsm-firmenich has announced the launch of CBtru® – an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.
dsm-firmenich is proud to announce its new strategic collaboration with Oz Medicann Group (OMG), to explore the therapeutic potential of cannabidiol (CBD) bases orally dispersible tablets addressing insomnia.
dsm-firmenich is proud to announce its strategic partnership with Zerion Pharma, to unlock a new era in cannabinoid innovation.
Stay up-to-date on the latest science, events and market trends
